Intexon Prepares to Issue IPO
Wednesday, July 10, 2013
Intrexon Corporation, founded in Blacksburg, has filed a
registration statement with the Securities and Exchange Commission
relating to the proposed initial public offering of its common stock.
IPO, which Intrexon filed as an "emerging growth company,” is designed
to raise $125 million and trade on the New York Stock Exchange under the
symbol XON. The number of shares to be offered and the price range for
the offering have not yet been determined.
Earlier this month the
synthetic biology company broadened its existing collaboration with
Fibrocell Science. This move along with a number of other
collaborations is designed to align its industry markets to focus on
four key sectors: Health, Food, Energy and Environment.
from the initial public offering would fund continued investment in the
company’s research and development platforms as well as push additional
collaboration agreements, according to the filing.
J.P. Morgan and Barclays will serve as joint book-running managers in the proposed offering.